Comments for: FDA advisers want warning on osteoporosis drugs

Posted Sept. 10, 2011, at 5:34 a.m.

TRENTON, N.J. — Food and Drug Administration advisers voted Friday to require makers of widely used osteoporosis drugs to clarify how long patients should take them for the greatest benefit and least risk. The FDA itself will later decide what the new label wording should say for each of the …

Guidelines for posting on bangordailynews.com

The Bangor Daily News encourages comments about stories, but you must follow our terms of service.

  1. Keep it civil and stay on topic
  2. No vulgarity, racial slurs, name-calling or personal attacks.
  3. People who harass others or joke about tragedies will be blocked.
The primary rule here is pretty simple: Treat others with the same respect you'd want for yourself. Here are some guidelines (see more):

Similar Articles

ADVERTISEMENT | Grow your business
ADVERTISEMENT | Grow your business